ISSN 1518 0557
Oocyte cryopreservation for future fertility: comparison of ovarian response between cancer and non-cancer patients

2019; 23
Camila Moraes, Victoria Furquim Werneck Marinho, Ana Luísa Menezes Campos, Janaína de Souza Guedes, Érica Becker de Sousa Xavier, João Pedro Junqueira Caetano, Ricardo Mello Marinho
JBRA Assist. Reprod. 2019; 23 (2):91-98

Received February 16, 2018
Accepted December 14, 2018
Abstract

Objective: evaluate if the occurrence of a diagnosis of cancer interferes in ovarian function, prior to the treatment of the disease. Material and methods: data from medical records, for this observational retrospective study, about ovarian stimulation cycles for oocytes cryopreservation. Results: The mean age was 35.13 ± 3.72 years, and 51.6% of the pacients were between 36 and 40 years. The majority of patients were single, 57.6% in both groups. 82.1% of the patients presented normal body mass index (BMI) in both groups. Most women had no pregnancies (85.5%), no births (95.1%), and no abortions (89.6%) prior to cryopreservation. The mean number of oocytes obtained for non-cancer patients was 11.4 ± 8 and for cancer patients this number was 13.8 ± 9. The mean number of frozen mature oocytes was 9.7 ± 7 for the non-oncological group and 11.2 ± 7.2 for the oncological group. The majority (63.1%) of the patients had up to 10 oocytes frozen per cycle. The most incident cancer was the breast cancer. There was no significant difference in ovarian response according to the type of cancer. Conclusion: The response to ovarian stimulation of oncological and non-oncological patients was similar, according to the number of oocytes obtained and frozen from the two groups.


This Article

doi: 10.5935/1518-0557.20190010

Full Text (HTML)
Full Text (PDF)

Classifications

Original article

Send this article

Send this article by mail

Access statistics

Last 30 days: 52
All time: 2094


Home

 
Copyright 2026 - JBRA Assisted Reproduction - All rights reserved.
Support and Maintenance by Eniosoft